Northern Trust’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Northern Trust’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-346,261	Closed	-$16.1M	–	4582
2023 Q2	$16.1M	Buy	346,261 +37,264	+12%	+$1.29M	﹤0.01%	1739
2023 Q1	$8.85M	Sell	308,997 -140	-0%	-$4.15K	﹤0.01%	2100
2022 Q4	$9.65M	Buy	309,137 +78,657	+34%	+$2.57M	﹤0.01%	2038
2022 Q3	$4.67M	Buy	230,480 +17,367	+8%	+$316K	﹤0.01%	2535
2022 Q2	$3.31M	Buy	213,113 +93,893	+79%	+$1.61M	﹤0.01%	2774
2022 Q1	$2.28M	Sell	119,220 -5,548	-4%	-$99K	﹤0.01%	3034
2021 Q4	$3.16M	Buy	+124,768	New	+$3.66M	﹤0.01%	2984

Northern Trust's DICE Position: Q3 2023 in Review

Northern Trust sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 346,261 shares — an estimated $16.1M sold.

Northern Trust first reported a position in DICE in Q4 2021 and held it in 7 quarters. The position peaked at $16.1M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Northern Trust reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Northern Trust sold 346,261 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $16.1M.
Northern Trust first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Northern Trust's DICE Therapeutics, Inc. Common Stock position peaked at $16.1M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.